<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
EuroMed, Inc.
- --------------------------------------------------------------------------------
(Name of issuer)
Common Stock, par value $0.01 per share
- --------------------------------------------------------------------------------
(Title of class of securities)
298735101
--------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 7 Pages
<PAGE> 2
- --------------------------- ---------------------
CUSIP No. 298735101 13G Page 2 of 7 Pages
- --------------------------- ---------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dr. A. Francois Hinnen
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP * (a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
The Netherlands
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY --------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 1,945,130
--------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH
0
--------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,923,130
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,945,130
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES *
[ ]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
48.91%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
INDIVIDUAL
- --------------------------------------------------------------------------------
<PAGE> 3
- --------------------------- ---------------------
CUSIP No. 298735101 13G Page 3 of 6 Pages
- --------------------------- ---------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
B.V. Wisteria
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP * (a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
The Netherlands
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY --------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 1,945,130
--------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH
0
--------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,923,130
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,945,130
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES *
[ ]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
48.91%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
Limited Liability Corporation
- --------------------------------------------------------------------------------
<PAGE> 4
- --------------------------- ---------------------
CUSIP No. 298735101 13G Page 4 of 7 Pages
- --------------------------- ---------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Pantapharma B. V.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP * (a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
The Netherlands
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY --------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 1,945,130
--------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH
0
--------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,923,130
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,945,130
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES *
[ ]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
48.91%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
Limited Liability Corporation
- --------------------------------------------------------------------------------
<PAGE> 5
Item 1(a). Name of Issuer.
EuroMed, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices.
Wilhelminakanaal Noord 6, NL 4092 VR Oosterhout, The Netherlands
Item 2(a). Name of Person Filing.
Dr. A. Francois Hinnen, individually, Pantapharma B.V., a Nether
lands private limited liability company, and B.V. Wisteria, a
Netherlands limited liability company.
Item 2(b). Address of Principal Business Office or, if none, Residence.
The principal business address of Dr. Hinnen, Pantapharma B.V.
and B.V. Wisteria is Beekhuizenseweg 87, 6881 AG Velp
Item 2(c). Citizenship.
Dr. Hinnen is a citizen of The Netherlands, Pantapharma B.V. is a
Netherlands private limited liability company, and B.V. Wisteria
is a Netherlands limited liability corporation.
Item 2(d). Title of Class of Securities.
Common Stock, par value of $0.01 per share ("Common Stock") of
the Issuer.
Item 2(e). CUSIP Number.
298735101
Item 3. Not Applicable.
Item 4. Ownership.
(a)-(b) Amount Beneficially Owned and Percent of Class.
As of December 31, 1996, 1,945,130 shares, or 48.91%, of
the Common Stock of the Issuer were owned by B.V. Wisteria and by
Dr. Hinnen and Pantapharma B.V. indirectly. Dr. Hinnen owns 100%
of Pantapharma B.V. which in turn owns 100% of B.V. Wisteria.
(c) Voting and Dispositive Power
(i) Sole power to vote or to direct the vote of: 0.
(ii) shared power to vote or to direct the vote: 1,945,130
Page 5 of 7 Pages
<PAGE> 6
(iii) sole power to dispose or direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of:
1,923,130
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not applicable
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent
Holding Company.
Not applicable
Item 8. Identification and Classification of Members of the Group.
Not applicable
Item 9. Notice of Dissolution of Group.
Not applicable
Item 10. Certification.
Not applicable
Page 5 of 7 Pages
<PAGE> 7
- --------------------------- ---------------------
CUSIP No. 298735101 13G Page 6 of 7 Pages
- --------------------------- ---------------------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 13, 1997
By: /s/ Dr. A. Francois Hinnen
-------------------------------------
Dr. A. Francois Hinnen
B.V. WISTERIA
By: /s/ Dr. A. Francois Hinnen
-------------------------------------
Dr. A. Francois Hinnen, Owner
PANTAPHARMA B.V.
By: /s/ Dr. A. Francois Hinnen
-------------------------------------
Dr. A. Francois Hinnen, Owner
<PAGE> 8
CUSIP NO. 298735101 13G
EXHIBIT A
Pursuant to Rule 13d-1(f)(1)(iii) of Regulation 13D of the General Rules
and Regulations of the Securities and Exchange Commission under the Securities
Exchange Act of 1934, as amended, the undersigned agree that the statement to
which this Exhibit is attached is filed on behalf of each of them.
PANTAPHARMA B.V.
By: /s/ Dr. A. Francois Hinnen
-----------------------------------------
Dr. A. Francois Hinnen, Owner
B.V. WISTERIA
By: /s/ Dr. A. Francois Hinnen
----------------------------------------
Dr. A. Francois Hinnen, Owner
/s/ Dr. A. Francois Hinnen
---------------------------------------------
Dr. A. Francois Hinnen
Dated: February 13, 1997
